Extended maintenance therapy leads to better clinical outcomes²

• Relapse rates were reduced in patients receiving long-term RTX    
  treatment

  compared to standard maintenance therapy
• With standard maintenance therapy, relapse rates remain high. At month 28, 25% of patients experienced a relapse
• There was no difference in the incidence of AEs with long-term treatment